First Eagle Investment Management
ALXN

First Eagle Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

First Eagle Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$4.49M – 113
2020
Q1 		$4.49M Buy
+50,000
New +$4.91M 0.02% 101
2019
Q4 		– Hold
0
– – – 114
2019
Q3 		– Hold
0
– – – 162
2019
Q2 		– Sell
-145,900
Closed -$19.7M – 166
2019
Q1 		$19.7M Hold
145,900
– – 0.05% 103
2018
Q4 		$14.2M Sell
145,900
-124,682
-46% -$14.7M 0.04% 111
2018
Q3 		$37.6M Buy
270,582
+55,600
+26% +$6.97M 0.09% 95
2018
Q2 		$26.7M Buy
+214,982
New +$25.1M 0.07% 108

Other funds holding ALXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return